Authors
Latest:
Future Research and Questions Surrounding GFAP, sTREM2 in Alzheimer Disease: Lynn Bekris, PhDThe molecular biologist at the Cleveland Clinic Lerner Research Institute provided insight on the lingering questions about GFAP and sTREM2 astrocytes, and their immunologic correlations with Alzheimer disease and related dementias. [WATCH TIME: 4 minutes]
Latest:
Approval of Aducanumab for Treatment of Alzheimer Disease: Eric Reiman, MDThe executive director of Banner Alzheimer’s Institute discussed the approval of aducanumab and the potential to address unmet needs and gaps in care for patients with Alzheimer disease.
Latest:
Are Apps the Answer? Access in Multiple Sclerosis CareA feature on NeurologyLive®, IJMSC Insights offers a closer look at the latest research and the people behind it from the community of the International Journal of Multiple Sclerosis Care (IJMSC) and the Consortium of Multiple Sclerosis Centers (CMSC).
Latest:
NeurologyLive® Brain Games: March 20, 2022Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is optic neuritis and neuromyelitis optica spectrum disorder (NMOSD).
Latest:
The Rising Prevalence and Behavioral Implications of Dementia in Parkinson Disease: Nahid Mohammadzadeh, MDAt AMTRD 2023, the graduate research assistant at Brown University talked about the prevalence of rapidly progressive dementia and cognition fluctuation in Parkinson disease as well as the effects of treatments for the condition. [WATCH TIME: 5 minutes]
Latest:
Significance of New MOGAD Diagnosis Criteria, Inclusion of MOG-IgG: Anastasia Vishnevetsky, MDAn immunology fellow at Brigham and Women’s Hospital provided perspective on the positive impacts a new diagnostic criterion for MOGAD brings to the clinical community. [WATCH TIME: 4 minutes]
Latest:
Evaluating the Education Process for Migraine Care: Courtney White, MDThe headache specialist at Jefferson Headache Center discussed the need to revamp the education process for migraine care and how much time residents spend learning about the disease. [WATCH TIME: 2 minutes]
Latest:
BTKi Treatment ParadigmNeurology experts discuss where BTKi’s fit in the multiple sclerosis treatment continuum.
Latest:
Navigating Treatment Decision-Making in Multiple SclerosisIn a paradigm with many options, once multiple sclerosis is confirmed as a patient’s diagnosis, physicians are left with 1 question: What do we choose for long-term treatment?
Latest:
The Complexity of Frontotemporal Dementia and Potential of COYA 301: Stanley H. Appel, MDThe director of the Ann Kimball and John W. Johnson Center for Cellular Therapeutics at Houston Methodist Hospital discussed the clinical manifestations of frontotemporal dementia (FTD) and how Coya Therapeutics is moving toward precision medicine with their FTD candidate, COYA 301. [WATCH TIME: 4 minutes]
Latest:
Using New Models to Explore the Origins of Parkinson Disease: Ray Dorsey, MDThe professor of neurology at University of Rochester discussed a new model on how Parkinson disease may originate, highlighting potential environmental causes and progression. [WATCH TIME: 5 minutes]
Latest:
Importance of Coordination in ALS Collaborative Research: Kuldip Dave, PhDThe senior vice president of research at The ALS Association talked about the complexities of ALS and the importance of collaboration in research at the 2023 MDA conference. [WATCH TIME: 5 minutes]
Latest:
Recognizing Health Disparities in Infantile Spasms at Local and National Levels: Kerri Neville, MDThe pediatric neurologist and epileptologist at the University of Michigan's Mott Children's Hospital spoke at the 2022 AES conference about disparities that currently exist in epilepsy care. [WATCH TIME: 4 minutes]
Latest:
Restoring Dystrophin Protein Production in DMD With Exon Skipping AOC Therapy: Steve Hughes, MDThe chief medical officer at Avidity Biosciences talked about how its exon skipping AOC therapies are designed to address the lack of functional dystrophin protein among patients with Duchenne muscular dystrophy to improve muscle function. [WATCH TIME: 4 minutes]
Latest:
Jude Savarraj, PhD: Applying Machine Learning to HealthcareThe research scientist from the University of Texas Medical School discussed some of the challenges and opportunities that machine learning presents in patient care.
Latest:
Therapeutic Avenues for Multiple Sclerosis Through Immune Cell Communication: Jeffrey Huang, PhDThe associate professor of biology at Georgetown University talked about how immune cells can communicate with brain cells to enhance repair processes, which may offer potential treatment targets for multiple sclerosis. [WATCH TIME: 5 minutes]
Latest:
Impacts of Daylight Savings Time on Sleep, Overall Health: Karin Johnson, MD, FAASMThe professor of neurology at UMass Chan School of Medicine discussed the various impacts Daylight Savings Time has on sleep quality and overall health in children and adolescents. [WATCH TIME: 3 minutes]
Latest:
Clinicians’ Role in Addressing the Neurologist Shortage: Jennifer Majersik, MD, MSThe division chief of vascular neurology at the University of Utah discussed the individual role that clinicians and neurologists can play to increase interest in the field of neurology. [WATCH TIME: 2 minutes]
Latest:
Ethical Values and Principals in Neurology Departments, Medical SchoolA group of esteemed panelists discussed the important values neurology department directors and educators should prioritize when teaching students of the future. [WATCH TIME: 6 minutes]
Latest:
Living Up to the Gold Standard in Parkinson Disease: Jennifer S. Hui, MDThe assistant professor of neurology at the Keck School of Medicine at University of Southern California discussed the importance of having additional agents to treat Parkinson disease.
Latest:
Using Nonamnestic Cognitive Symptoms to Predict Trajectories of Neurodegenerative Disorders: Jagan A. Pillai, MD, PhDThe neurologist at Cleveland Clinic’s Lou Ruvo Center for Brain Health detailed new findings on whether initial cognitive symptoms have similar rates of functional decline across a handful of neurodegenerative disorders. [WATCH TIME: 3 minutes]
Latest:
Understanding the Cognitive Impact of Neighborhood Disadvantage on Black Women: Tanisha Hill-Jarrett, PhDThe neuropsychologist and assistant professor of neurology at the University of California, San Francisco Memory and Aging Center provided comment on her presentation from AAN 2024 examining the association of area deprivation index with cognitive functioning in Black women. [WATCH TIME: 3 minutes]
Latest:
Areas of Need in Epilepsy Research: Barbara Jobst, MDThe director of the Dartmouth Epilepsy Program provided an overview of some of the critical unmet needs within ongoing epilepsy research following the recent AES Annual Meeting.
Latest:
Early Awareness Towards Epilepsy TransitionSucheta M. Joshi, MD, MS, FAES, FAAP, and Nicholas Beimer, MD, discussed the reasons why EpiTRAQ may influence earlier discussions with patients prior to the epilepsy transition process.
Latest:
Neurostimulation and Targeted Treatment Delivery in Epilepsy Care: Martha Morrell, MDThe clinical professor of neurology at Stanford University School of Medicine talked about the collaboration of Rapport leveraging NeuroPace’s data analysis capabilities to study the target delivery of a therapy for focal epilepsy. [WATCH TIME: 5 minutes]
Latest:
Diagnosis Through Teleneurology: Jason Poon, MDThe neurologist at University of Utah discussed the potential of using teleneurology to diagnose neurological conditions.
Latest:
Understanding Irsenontrine’s Role Among Neurodegenerative Disorders: Michael Irizarry, MD, PhDThe senior VP of clinical research at Eisai discussed findings from a phase 2 study assessing irsenontrine in patients with dementia with Lewy bodies and Parkinson disease dementia. [WATCH TIME: 4 minutes]
